SHANGHAI PHARMACEUTICALS HOLDING CO financial statements, including revenue, expenses, and profit
The total revenue of 601607 for the last quarter is 65.44 B CNY, and it's 6.54% lower compared to the previous quarter. The net income of Q4 24 is 498.35 M CNY.